Page last updated: 2024-08-26

3,7-dimethyl-1-propargylxanthine and fluoxetine

3,7-dimethyl-1-propargylxanthine has been researched along with fluoxetine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaneko, S; Kawata, Y; Kondo, T; Mizuno, K; Murakami, T; Okada, M; Wada, K1
Brumand, K; Deemyad, T; Malihi, G; Pousti, A1

Other Studies

2 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and fluoxetine

ArticleYear
Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.
    The European journal of neuroscience, 1999, Volume: 11, Issue:1

    Topics: Adenosine; Animals; Antihypertensive Agents; Biological Transport; Caffeine; Central Nervous System Stimulants; Fluoxetine; Hippocampus; Male; Microdialysis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quipazine; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Theobromine; Theophylline; Vasodilator Agents

1999
Involvement of adenosine in the effect of fluoxetine on isolated guinea-pig atria.
    Pharmacological research, 2006, Volume: 53, Issue:1

    Topics: Adenosine; Animals; Antidepressive Agents, Second-Generation; Depression, Chemical; Female; Fluoxetine; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theobromine; Xanthines

2006